JP2025510781A5 - - Google Patents

Info

Publication number
JP2025510781A5
JP2025510781A5 JP2024556421A JP2024556421A JP2025510781A5 JP 2025510781 A5 JP2025510781 A5 JP 2025510781A5 JP 2024556421 A JP2024556421 A JP 2024556421A JP 2024556421 A JP2024556421 A JP 2024556421A JP 2025510781 A5 JP2025510781 A5 JP 2025510781A5
Authority
JP
Japan
Prior art keywords
recombinant gene
polypeptide
amino acid
effector
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024556421A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025510781A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/064887 external-priority patent/WO2023183893A1/en
Publication of JP2025510781A publication Critical patent/JP2025510781A/ja
Publication of JP2025510781A5 publication Critical patent/JP2025510781A5/ja
Pending legal-status Critical Current

Links

JP2024556421A 2022-03-24 2023-03-23 組換え遺伝子エフェクターならびにその組成物および使用方法 Pending JP2025510781A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US202263323248P 2022-03-24 2022-03-24
US63/323,248 2022-03-24
US202263381255P 2022-10-27 2022-10-27
US63/381,255 2022-10-27
US202363489873P 2023-03-13 2023-03-13
US63/489,873 2023-03-13
PCT/US2023/064887 WO2023183893A1 (en) 2022-03-24 2023-03-23 Engineered gene effectors, compositions, and methods of use thereof

Publications (2)

Publication Number Publication Date
JP2025510781A JP2025510781A (ja) 2025-04-15
JP2025510781A5 true JP2025510781A5 (cg-RX-API-DMAC7.html) 2026-03-25

Family

ID=88102034

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024556421A Pending JP2025510781A (ja) 2022-03-24 2023-03-23 組換え遺伝子エフェクターならびにその組成物および使用方法

Country Status (7)

Country Link
US (1) US20250388634A1 (cg-RX-API-DMAC7.html)
EP (1) EP4499838A4 (cg-RX-API-DMAC7.html)
JP (1) JP2025510781A (cg-RX-API-DMAC7.html)
CN (1) CN119256086A (cg-RX-API-DMAC7.html)
AU (1) AU2023241162A1 (cg-RX-API-DMAC7.html)
CA (1) CA3253453A1 (cg-RX-API-DMAC7.html)
WO (1) WO2023183893A1 (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2025507822A (ja) 2022-03-01 2025-03-21 エピクリスパー バイオテクノロジーズ, インコーポレイテッド 組換えヌクレアーゼならびにその組成物および使用方法
CN116769916B (zh) * 2023-06-27 2025-03-07 南通大学附属医院 Tmed8基因在制备胰腺癌药物及其诊断试剂盒中的应用
EP4774383A1 (en) 2023-09-06 2026-07-15 Epicrispr Biotechnologies, Inc. Engineered cas12 polypeptides, compositions, and methods of use thereof
WO2026090457A1 (en) * 2024-10-25 2026-04-30 Stark Therapeutics Corporation Methods of treatment of metabolic diseases

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024526895A (ja) * 2021-07-20 2024-07-19 エピクリスパー バイオテクノロジーズ, インコーポレイテッド 標的遺伝子を調節するための系および方法

Similar Documents

Publication Publication Date Title
Emili et al. Species-specific interaction of the glutamine-rich activation domains of Spl with the TATA box-binding protein
JP2025063029A5 (cg-RX-API-DMAC7.html)
JP2022522650A5 (cg-RX-API-DMAC7.html)
Matuoka et al. A novel ligand for an SH3 domain of the adaptor protein Nck bears an SH2 domain and nuclear signaling motifs
JP2023512824A5 (cg-RX-API-DMAC7.html)
JP2025114573A5 (cg-RX-API-DMAC7.html)
JP2017018125A5 (cg-RX-API-DMAC7.html)
CA2386471C (en) Purification of recombinant proteins fused to multiple epitopes
JP2001506851A (ja) 原核生物の二ハイブリッド系
US7045677B2 (en) Fusion proteins incorporating lysozyme
JPWO2021117848A5 (cg-RX-API-DMAC7.html)
Ehrenman et al. Characterization of cDNAs encoding the murine A+ U-rich RNA-binding protein AUF1
JP2022545625A5 (cg-RX-API-DMAC7.html)
JP2003511014A5 (cg-RX-API-DMAC7.html)
EP1131448A2 (en) Producing antimicrobial cationic peptides as fusion proteins
US20050260715A1 (en) Efficient methods for producing antimicrobial cationic peptides in host cells
JPWO2023038128A5 (cg-RX-API-DMAC7.html)
JP2009291139A (ja) 真核細胞において組換えタンパク質を細胞外に放出させるためのポリヌクレオチド
JP2024513231A5 (cg-RX-API-DMAC7.html)
CN100584945C (zh) 调节基因表达的核被膜和核纤层结合嵌合体
JPWO2023120658A5 (cg-RX-API-DMAC7.html)
JP2023532415A5 (cg-RX-API-DMAC7.html)
US11208444B2 (en) BRCA2-mediated purification of recombinase protein
US20050100894A1 (en) Novel mitogen activated kinase
WO2026088062A1 (en) Artificial transcription factors